Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.2995
Delayed Data
As of Apr 19
 +0.0034 / +1.15%
Today’s Change
0.29
Today|||52-Week Range
0.68
-16.46%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.30
Today’s open0.31
Day’s range0.29 - 0.33
Volume1,131,331
Average volume (3 months)315,402
Market cap$62.4M
Data as of 3:59pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+2.22%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-91.76%
P/E ratioNM
Price/Sales32.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Internatio...-0.03-5.94%
SPHSSophiris Bio Inc+0.02+0.93%
PTNPalatin Technologies...-0.02-1.49%
NBYNovaBay Pharmaceutic...+0.10+3.08%
Data as of 8:00pm ET, 04/19/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.2M
Net profit margin-758.21%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
CFO, COO, Secretary &
Treasurer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts